Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Champions Oncology Inc., 3 years.
Champions Oncology Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Champions Oncology Inc. October 16, 202595.0%
-
Champions Oncology Inc. October 14, 202484.8%
-
Champions Oncology Inc. October 19, 202385.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 12, 2024 | Champions Oncology Inc. | Open-market purchase | +1,000 | $6.50 | $6,500 |
| Jan 11, 2024 | Champions Oncology Inc. | Open-market purchase | +2,000 | $6.27 | $12,540 |
| Jan 10, 2024 | Champions Oncology Inc. | Open-market purchase | +2,944 | $6.31 | $18,577 |
| Jan 9, 2024 | Champions Oncology Inc. | Open-market purchase | +3,000 | $6.25 | $18,750 |
| Jan 8, 2024 | Champions Oncology Inc. | Open-market purchase | +1,000 | $6.15 | $6,150 |
| Jan 5, 2024 | Champions Oncology Inc. | Open-market purchase | +2,000 | $6.09 | $12,180 |
| Jan 4, 2024 | Champions Oncology Inc. | Open-market purchase | +3,000 | $6.12 | $18,360 |
| Jan 3, 2024 | Champions Oncology Inc. | Open-market purchase | +500 | $5.83 | $2,915 |
| Dec 21, 2023 | Champions Oncology Inc. | Open-market purchase | +2,500 | $4.92 | $12,300 |
| Dec 20, 2023 | Champions Oncology Inc. | Open-market purchase | +2,100 | $4.82 | $10,122 |
| Dec 19, 2023 | Champions Oncology Inc. | Open-market purchase | +5,000 | $4.75 | $23,750 |
| Oct 11, 2023 | Champions Oncology Inc. | Open-market purchase | +5,000 | $6.40 | $32,000 |
| Oct 10, 2023 | Champions Oncology Inc. | Open-market purchase | +1,100 | $6.41 | $7,051 |
| Oct 6, 2023 | Champions Oncology Inc. | Open-market purchase | +1,530 | $6.48 | $9,914 |
| Oct 5, 2023 | Champions Oncology Inc. | Open-market purchase | +2,000 | $6.47 | $12,940 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.